SU056
SU056 is a YB-1 inhibitor. SU056 induces cell-cycle arrest, apoptosis, and inhibits cell migration in ovarian cancer cells. SU056 interacts with YB-1 and inhibits and its associated downstream proteins and pathways. SU056 can enhance the cytotoxic effects of Paclitaxel (HY-B0015) [1].
Product Specifications
CAS Number
[2376580-08-2]
UNSPSC
12352005
Target
YB-1
Type
Reference compound
Related Pathways
Cell Cycle/DNA Damage
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/su056.html
Purity
99.77
Solubility
DMSO : 50 mg/mL (ultrasonic)
Smiles
O=C1OCC2=C1C(C3=CC4=C(C=C3N2CCO)OCO4)C5=CC(F)=CC=C5
Molecular Formula
C20H16FNO5
Molecular Weight
369.34
References & Citations
[1]Tailor D, et al. Y box binding protein 1 inhibition as a targeted therapy for ovarian cancer. Cell Chem Biol. 2021 Aug 19;28 (8) :1206-1220.e6.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
Recombinant Escherichia coli Lipid A biosynthesis lauroyl acyltransferase (htrB)
Recombinant Escherichia coli Lipid A biosynthesis lauroyl acyltransferase (htrB)
Recombinant Escherichia coli Lipid A biosynthesis lauroyl acyltransferase (htrB)
Lentiviral human POGLUT1 shRNA (UAS) - Lentiviral human POGLUT1 shRNA (UAS, RFP) plasmid
Lentiviral human FIZ1 sgRNA gene knockout kit - Lentiviral human FIZ1 sgRNA gene knockout kit (25)
